During the past decade, Ospedale SS. Annunziata conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 10 clinical trials were completed, i.e. on average, 26.3% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 8 clinical trials were completed. i.e. 38.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale SS. Annunziata" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Celgene" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "G. d'Annunzio University" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale SS. Annunziata" #1 collaborator was "Itreas" with 2 trials as a collaborator, "1Med" with 1 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator and "Azienda Sanitaria Locale n. 2 - Lanciano Vasto Chieti" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale SS. Annunziata" are "Idiopathic Pulmonary Fibrosis" (4 trials), "Crohn Disease" (3 trials), "Deep Venous Thrombosis" (3 trials), "Pulmonary Embolism" (3 trials) and "Venous Thromboembolism" (3 trials). Many other conditions were trialed in "Ospedale SS. Annunziata" in a lesser frequency.

Most popular intervention types in "Ospedale SS. Annunziata" are "Drug" (29 trials), "Other" (10 trials), "Biological" (6 trials), "Dietary Supplement" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Baricitinib" (3 trials), "Carboplatin" (3 trials), "Ozanimod" (3 trials) and "Pemetrexed" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale SS. Annunziata" are 43 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale SS. Annunziata". undefined are not yet recruiting, 18 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Ospedale SS. Annunziata, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale SS. Annunziata, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".